Structural characteristics of compounds that modulate P-glycoprotein-associated multidrug resistance

Area of Science:

• Biochemistry
• Pharmacology
• Medicinal Chemistry

Background:

• Multidrug resistance (MDR) is a major challenge in cancer chemotherapy, often mediated by P-glycoprotein (P-gp).
• P-gp acts as an energy-dependent efflux pump, reducing intracellular anticancer drug concentrations and conferring resistance.
• Compounds modulating P-gp activity can potentially overcome MDR and enhance chemotherapy efficacy.

Purpose of the Study:

• To identify the key structural features of compounds that modulate P-glycoprotein (P-gp) activity.
• To establish a pharmacophore model for P-gp binding and inhibition.
• To guide the rational design of novel MDR modulators.

Main Methods:

• Utilized a photoactivatable vinblastine analog as a probe to study P-gp interactions.
• Synthesized and analyzed a series of reserpine and yohimbine analogs.
• Employed three-dimensional structural comparisons to analyze various modulator classes, including condensed-ring aromatics.

Main Results:

• Established that two planar aromatic domains and a basic nitrogen atom are critical structural requirements for P-gp modulators.
• Demonstrated structural similarities among different classes of MDR modulators, suggesting a common binding site on P-gp.
• Identified key features contributing to the effectiveness of MDR modulators based on physical properties like size and shape.

Conclusions:

• The findings emphasize a ligand-receptor interaction model for P-gp modulators.
• Defined initial aspects of the P-gp binding pharmacophore.
• This approach can direct the synthesis of new compounds to modulate MDR and understand P-gp molecular recognition.